Tonix Pharmaceuticals Holding Corp (TNXP)

[XWAVXALMIMAN]

Tonix had great news on 5/17 - huge potential
https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-pharmacology-medicinal-110000260.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAE7tFxmE8Z0WjW38hWQgtZKT8v79B_38ZvR_gD7glijyZtdB_yPENydO6EF__62zQOyFK6xuP4s0RNkE92Zj5fVjJboGVuPneZljc3DLevnwL6wDUDVgYnziedxq-4-s4eV6x9-aVuHiP27Hgw2jSQlnRRmLRTzoNdvFyr0ifArG

Tianeptine is approved for depression and anxiety in Europe, Asia and South America. It works as well as other antidepressants without the side effects of sexual dysfunction and weight gain. It also may help Bipolar, Parkinson’s and Alzheimer’s.
Our CEO Lis presenting data at a conference this week. Stephen Stahl quoted in above article is one of the best Psychopharmacologists in the country.

I am a Psychiatrist attending the APA convention in SF. 2 other prominent Psychiatrists talked about Tianeptine today and one of them told me that he gets it from Europe for his patients.

My question is: if this drugs has been approved for many years in Europe and is generic, how can Tonix get a patent to sell it as a brand name drug?